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Effect of prenatal dexamethasone on rat renal development. life [5–15]. Human infants born to mothers treated for
Background. Prenatal insults can program the developing infertility with prednisone (10 mg/day) throughout preg-
fetus to develop diseases that manifest in later life. Dexametha- nancy had intrauterine growth retardation [5]. Similarly,sone is often administered to the developing fetus to accelerate
rats and mice treated with dexamethasone daily through-pulmonary development. The purpose of the present study
out pregnancy had lower birth weights than vehicle-was to determine whether prenatal dexamethasone adversely
affects renal development and predisposes rats to develop renal treated controls [5–7].
disease and hypertension in later life. Normally, the fetus is protected from maternal steroids
Methods. Pregnant rats were given either vehicle or two by placental 11b-hydroxysteroid dehydrogenase, whichdaily intraperitoneal injections of dexamethasone (0.2 mg/kg
converts physiologic glucocorticoids to inactive metabo-body weight) on gestational days: 11 and 12, 13 and 14, 15 and
lites [6, 16]. Inhibition of this enzyme with carbenoxolone16, 17 and 18, 19 and 20, or 20 and 21. Tail cuff blood pressure,
glomerular number, and inulin clearance were measured in during pregnancy in rats results in intrauterine growth
control and prenatal dexamethasone-treated rats when the rats retardation [17]. Rats fed a low-protein diet during preg-
were 60 to 90 days of age.
nancy have lower placental 11b-hydroxysteroid dehydrog-Results. Prenatal dexamethasone did not affect the length
enase activity and greater exposure to maternal steroidsof gestation, the number of animals per litter, or the total body
weight or kidney weight measured at one day of age. Offspring [18]. This increased fetal exposure to glucocorticoids may
of rats administered dexamethasone on days 15 and 16 gesta- be a contributing factor in the development of intrauter-
tion had a 30% reduction in glomerular number compared ine growth retardation seen with dietary protein depriva-
with control at 60 to 70 days of age (24,236 6 441 vs. 30,453 6
tion during pregnancy [18].579, P , 0.01). Rats receiving prenatal dexamethasone on days
Recent studies have suggested that prolonged expo-17 and 18 had an approximate 20% reduction in glomeruli
compared with control (P , 0.01). Offspring of rats receiving sure to dexamethasone, which is not metabolized by
dexamethasone on days 15 and 16 gestation had systolic blood placental 11b-hydroxysteroid dehydrogenase, may have
pressures at 60 to 90 days of age that were higher than any an adverse effect on the developing kidney [7, 8, 12,other group (P , 0.05). The glomerular filtration rate was
13]. However, in these studies, the dose or duration ofcomparable in all of the groups.
administration of glucocorticoids resulted in intrauterineConclusions. This study shows that two daily doses of prena-
tal dexamethasone (0.2 mg/kg body weight) in rats do not pro- growth retardation. The purpose of the present study
duce intrauterine growth retardation. Adult offspring of rats was to examine whether the administration of glucocorti-
that received prenatal dexamethasone during specific times of
coids to pregnant rats at specific times of gestation af-gestation have a reduced number of nephrons and hypertension.
fected renal development and predisposed rats to de-
velop renal or cardiovascular disease in later life.
Antenatal glucocorticoid therapy reduces the inci-
dence of respiratory distress syndrome and mortality of METHODS
premature neonates [1–4]. However, it is possible that
Animalsantenatal glucocorticoid therapy may adversely affect fetal
Timed pregnant Sprague-Dawley rats arrived at ourdevelopment and have persistent consequences later in
institution at least two days before the initiation of the
study. The males are with the females for 15 hours, and
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day 0 of pregnancy was confirmed the next morning byretardation, glucocorticoids, hypertension, glomerular number, kidney
development. the presence of a vaginal plug. Pregnant rats received
either intraperitoneal vehicle or dexamethasone (0.2Received for publication April 3, 2000
mg/kg body weight) daily on gestational days 11 and 12,and in revised form October 25, 2000
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mothers until they were weaned when they were then a femoral arterial catheter placed above the renal arter-
ies. A second 0.2 cc per 100 g body weight bolus of alcianplaced on standard rat chow. Both male and female
blue was then administered five to seven minutes afterrats were studied. Prenatal dexamethasone resulted in
the first infusion. The kidneys were then removed fivecomparable differences from controls in males and fe-
minutes after the second infusion, sliced in half, andmales in each of the protocols studied, and the results
incubated in 5 cc of 27% ammonia for two hours at roomwere therefore combined except for blood pressure. Rats
temperature. The kidney was then incubated in 5 cc offrom at least two different litters were studied in each
8 N HCl at 508C for one hour. The suspension was dilutedprotocol. The pregnant rats were used only once.
to a final volume of 20 cc with water and incubated
Measurement of glomerular filtration rate overnight at 48C. The number of glomeruli in 10 30 mL
samples was counted using a light microscope and aver-Control and rats that received prenatal dexametha-
aged to determine the number of glomeruli per kidney.sone were allowed free access to food and water until
they were studied at 60 to 70 days of age. Rats were DNA and protein content
anesthetized with intraperitoneal Inactin (100 mg/kg)
Kidneys were removed from 1- and 60-day-old adultand placed on a servo-controlled heated table set to
rats that received prenatal dexamethasone. The organsmaintain a constant body temperature of 388C. Catheters
were blotted to remove any blood and were weighed
were placed in the internal jugular vein and carotid ar- and frozen in liquid nitrogen. The organs were stored at
tery, and a tracheostomy was performed. A bladder cath-
2808C until study. Organs were homogenized in phos-
eter was placed to ensure free flow of urine. Normal phate-buffered saline (PBS; pH 5 7.4) with a Teflon-
saline was infused at 0.6 cc/kg per hour. Inulin clearance glass homogenizer at 48C, and an aliquot was removed
was performed in a similar fashion to that previously for measurement of protein and DNA content. Protein
described [19]. Briefly, a prime of 6 mCi 3H-methoxy was measured using the bicinchoninic acid assay (BCA;
inulin was infused followed by a maintenance intrave- Pierce Chemical Company, Rockford, IL, USA) using
nous infusion of 16 mCi per hour. After one hour of bovine serum albumin as the standard. DNA was assayed
equilibration, at least three 30-minute urine and mid- using the technique of Labarca and Paigen [23].
point blood samples were collected for analysis of [me-
Histology and glomerular sizethoxy-3H] inulin using liquid scintillation counting. The
mean of the clearance periods was used as the measure- Kidneys from four 60- to 70-day-old control rats and
ment of glomerular filtration rate. There was no differ- four rats that received prenatal dexamethasone on days
15 and 16 gestation were fixed in 10% phosphate-buf-ence in the glomerular filtration rate in the three periods.
fered formalin, embedded in paraffin, sectioned at 4 mi-The glomerular filtration rates were 2.27 6 0.07, 2.35 6
crons, and stained with periodic acid-Schiff stain. One0.07, and 2.45 6 0.09 mL/min in the first three periods,
hundred glomeruli from each animal were examined forrespectively.
evidence of glomerulosclerosis. For estimation of glo-
Measurement of blood pressure merular size, slides were evaluated at 340 magnification
with a Zeiss microscope on an Autocyte PathologyBlood pressure was measured in 60- to 90-day-old
Workstation (Tripath Imaging, Burlington, NC, USA).rats using an IITC Model 179 blood pressure analyzer
The perimeters of 100 glomeruli from each animal were(Landing, NJ, USA). Animals were placed in a Lucite
outlined, and the glomerular area was determined usingtube, and a tail cuff blood pressure cuff was inflated
Autocyte Quic DNA software (Tripath Imaging, Burl-several times daily on the three days prior to the actual
ington, NC, USA). Measurement was conducted withoutmeasurement of blood pressure. The rat was then re-
knowledge of the whether the animal was a control orturned to the animal care facility. On the day of the
a rat that received prenatal dexamethasone.actual measurement, blood pressure was measured four
times, and the mean of these values was used as the Statistical analysis
blood pressure for that rat. Values are expressed as mean 6 SEM. Analysis of
variance was used to determine statistical significanceGlomerular number
except for studies examining number of sclerotic glomer-
Glomerular number was determined using a variation uli, where chi-square analysis was used.
of the technique of Damadian, Shwayri, and Bricker with
significant modifications [20–22]. Alcian blue is superior
RESULTSto India ink to stain glomeruli [20, 22]. After measure-
Effect of prenatal dexamethasone on litter sizement of glomerular filtration rate, the rats received an
and gestationintra-arterial infusion of 0.2 cc per 100 g body weight of
5% alcian blue (Aldrich Chemical Company, Milwau- There was an average of 9.8 6 0.9 rats per litter in
the control group, which was not different from any ofkee, WI, USA) in normal saline over one minute using
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Table 1. Effect of prenatal dexamethasone (Dex) on rat body and kidney weight and kidney DNA and protein content at one day of age
Dexamethasone, days
Control 11 and 12 13 and 14 15 and 16 17 and 18 19 and 20 20 and 21
Body g 5.9560.11 6.3760.14 6.2760.16 6.0660.09 5.8760.07 5.6560.09a 6.0760.11
(70) (33) (33) (72) (50) (40) (50)
Kidney g 0.03460.001 0.03560.001 0.03260.001 0.03460.001 0.03160.001b 0.03260.001 0.03260.001b
(60) (31) (26) (70) (50) (44) (68)
DNA lg/kidney 80.965.1 81.266.0 99.964.0 83.662.4 104.467.2c 93.666.2 85.965.3
(14) (12) (15) (18) (14) (9) (14)
DNA mg/g tissue 2.560.2 2.860.3 3.160.2 2.660.1 3.560.2d 3.160.2 2.960.1
(14) (12) (15) (18) (14) (9) (14)
Protein mg/kidney 2.960.2 3.060.2 3.160.1 3.860.2e 3.560.2 2.960.2 3.360.2
(24) (19) (24) (24) (21) (14) (20)
Protein mg/g tissue 94.566.1 92.865.8 89.564.3 108.765.9 109.465.9 93.266.8 96.565.5
(24) (18) (24) (23) (21) (14) (22)
The number or determinations is in parentheses.
a Less than 11 & 12, 13 & 14 at P , 0.05
b Less than control, 11 & 12, 15 & 16 at P , 0.05
c Greater than control, 11 & 12, 15 and 16 at P , 0.05
d Greater than control and 15 & 16 at P , 0.05
e Greater than control, 11 & 12, 13 & 14, and 19 & 20 at P , 0.05
the prenatal dexamethasone-treated groups. The num- Table 2 shows the rat body and kidney weight as well
as the DNA and protein content at 60 days of age. Onlyber of animals per litter in the groups that received pre-
the DNA content in the 15 and 16 dexamethasone groupnatal dexamethasone on days 11 and 12, 13 and 14, 15
was different from that of the control. There was lessand 16, 17 and 18, 19 and 20, and 20 and 21 were 10.5 6
protein per gram of kidney in the 11- and 12-day dexa-1.1, 10.8 6 0.9, 9.8 6 0.9, 8.8 6 0.5, 9.6 6 0.8, and 10.5 6
methasone group compared with dexamethasone days0.4, respectively. The mean gestation in the control group
13 and 14, 15 and 16, and 20 and 21 groups, but this waswas 21.7 6 0.1 days and was not different than any
not significantly different than that in the controls.dexamethasone-treated group.
Effect of prenatal glucocorticoids on number of
Effect of prenatal glucocorticoids on postnatal glomeruli and glomerular filtration rate at two
body and kidney weight and kidney DNA and months of age
protein content The effect of prenatal dexamethasone on glomerular
The effect of prenatal dexamethasone on postnatal number was determined in rats at 60 to 70 days of age.
body weight is shown in Table 1. It is clear from this As shown in Figure 1, prenatal administration of gluco-
table that maternal administration of dexamethasone at corticoids on days 15 and 16 of gestation resulted in a
30% reduction in glomeruli compared with control andany of the time points does not produce intrauterine
fewer glomeruli than any of the other groups (P , 0.001).growth retardation. Only the group of animals born to
The rats that received dexamethasone on days 17 andmothers receiving dexamethasone on days 19 and 20
18 of gestation also had a reduction in the number ofwere somewhat smaller than those receiving dexametha-
glomeruli compared with all other groups except thesone on days 11 and 12 and 13 and 14, but they were
group that received dexamethasone on days 15 and 16not smaller than controls. The kidneys (left kidney) of
gestation (P , 0.01). As shown in Figure 2, despite theanimals that received dexamethasone on days 17 and 18
reduction in glomerular number, there was no differenceand 20 and 21 were slightly smaller than controls as well
in the glomerular filtration rate in any group.as the dexamethasone days 11 and 12 and 15 and 16
groups. As is shown in Table 1, the DNA content (left Effect of prenatal glucocorticoids on blood pressure at
kidney) was only different in the 17- and 18-day dexa- 60 to 90 days of age
methasone group and was actually greater than the con- We also assessed whether prenatal dexamethasone
trol and the dexamethasone 11- and 12-day and 15- and would result in an elevation in systolic blood pressure
16-day groups. The renal protein content (left kidney) when the rats reached 60 to 90 days of age. Control
was also comparable in all groups except in the 15- and males tended to have somewhat higher blood pressures
16-day group, where the content was greater than con- than females, and the results were divided by gender.
trols, as well as the dexamethasone days 11 and 12, 13 Control male systolic blood pressure was 143 6 3 com-
pared with 135 6 4 in females (P 5 0.11). The resultsand 14, 19 and 20 groups.
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Table 2. Effect of prenatal dexamethasone on rat body and kidney weight and kidney DNA and protein content at 60 days of age
Dexamethasone, days
Control 11 and 12 13 and 14 15 and 16 17 and 18 19 and 20 20 and 21
Body g 259.269.4 285.767.4 269.8612.0 264.066.9 245.568.1 248.367.4 264.369.3
(34) (26) (18) (35) (31) (21) (29)
Kidney g 1.0860.03 1.1260.04 1.0560.06 1.1360.03 1.0360.06 1.1460.03 0.9860.04
(38) (26) (18) (35) (24) (20) (31)
DNA mg/kidney 4.760.3 5.460.4 5.260.5 6.260.3a 4.760.3 4.660.4 5.060.3
(27) (22) (12) (30) (20) (21) (18)
DNA mg/g tissue 4.660.3 4.860.3 5.260.5 5.760.2 5.460.4 4.360.3 5.260.3
(27) (22) (12) (30) (19) (22) (18)
Protein mg/kidney 130.667.7 129.1611.5 149.869.7 158.966.8 125.568.9 143.666.6 137.868.8
(32) (20) (16) (28) (11) (17) (20)
Protein mg/g tissue 136.268.5 116.167.6b 149.468.4 146.762.8 131.664.8 125.964.2 144.966.4
(32) (20) (16) (29) (11) (17) (20)
The number of determinations is in parentheses.
a Greater than control, 17 & 18, and 19 & 20 at P , 0.05
b Less than 13 & 14, 15 & 16, 20 & 21
Fig. 1. Effect of prenatal dexamethasone on the number of glomeruli
in adult rats. Pregnant rats were administered either vehicle (Control)
Fig. 2. Effect of prenatal dexamethasone on glomerular filtration rateor dexamethasone (0.2 mg/kg body wt) on gestational days 11 and 12,
(GFR) at 60 days. Glomerular filtration rate was measured in anesthe-13 and 14, 15 and 16, 17 and 18, 19 and 20, 20 and 21. At 60 to 70 days
tized 60- to 70-day-old rats that received either prenatal dexamethasoneof age, the number of glomeruli was counted using alcian blue to stain
or vehicle (Control). GFR was measured using [methoxy-3H] inulin.the glomeruli followed by acid digestion. The number of glomeruli were
There was no difference in GFR in any of the groups. There were atreduced in animals that received dexamethasone either at 15 and 16 or
least 10 rats in each group.17 and 18 days of gestation. There were at least 20 rats in each group.
Symbols are: (1) less than other groups at P , 0.01; (11) less than
all other groups except for gestational days 15–16 at P , 0.001.
are shown in Figure 3. Prenatal dexamethasone adminis- there was no significant difference in the histology be-
tween the two groups. There was one sclerotic glomeru-tered on days 15 and 16 of gestation resulted in an in-
crease in systolic blood pressure in both males and fe- lus in 400 glomeruli examined from four control animals,
and three of 400 glomeruli had focal sclerosis from fourmale rats when studied at 60 to 90 days of age compared
with all other groups. The males that received prenatal offspring of animals that received prenatal dexametha-
sone on days 15 and 16 of gestation (P 5 NS). Wedexamethasone on days 17 and 18 of gestation had a
higher systolic blood pressure than that of the other also examined whether there was evidence of glomerular
hypertrophy in the offspring of rats that received dexa-groups except the 15- and 16-day group (P , 0.05).
methasone on days 15 and 16 of gestation. Glomerular
Histology and glomerular size area was 8149 6 165 square microns in the dexametha-
sone-treated group and 7755 6 151 in the control group.Histology of kidneys from 60-day-old control rats and
rats that received prenatal dexamethasone on days 15 This 5% difference did not reach statistical significance
(0.05 , P , 0.01).and 16 gestation is shown in Figure 4. As can be seen,
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Fig. 4. Low-power view (3100) of typical renal cortical field from a
control (A) and dexamethasone-treated animal (B) using periodic acid-
Schiff stain. The histologic features are similar in both animals. No
interstitial fibrosis or glomerular lesions are present.
steroid dehydrogenase results in hypertension when
treated rats become adults [17]. Pregnant rats fed a low-
protein diet have reduced placental 11b-hydroxysteroid
dehydrogenase activity, and the offspring develop sys-
tolic hypertension as adults [18]. Furthermore, inhibition
of glucocorticoid synthesis with metyrapone during the
first 14 days of gestation prevents the development of
hypertension in rats born to mothers fed a low-protein
diet during gestation [24].
Prenatal administration of pharmacologic doses of
dexamethasone, which is not metabolized by 11b-hydroxy-
steroid dehydrogenase, has previously been shown toFig. 3. Systolic blood pressure in 60- to 90-day-old rats that received
prenatal dexamethasone or vehicle. Blood pressure was taken in produce altered fetal renal development. The adminis-
trained rats using a tail cuff. Male (A) and female (B) rats that received tration of betamethasone to pregnant rhesus monkeysprenatal dexamethasone on days 15 and 16 of gestation developed
was shown 25 years ago to result in the narrowing of thehypertension, as did male rats that received dexamethasone on days
17 and 18 of gestation. There are at least eight rats in each group nephrogenic zone. This was interpreted as glucocorticoid
except days 20–21, where there were five females and four males. induced acceleration in renal development [8]. However,*Greater than all other groups at P , 0.05; 1greater than all groups
other studies have shown that the administration of glu-except the dexamethasone on gestational days 15–16 group.
cocorticoids to pregnant rats results in a decrease in
neonatal weight, in total DNA content and a decrease
in 3H-thymidine incorporation in the kidney as well as
DISCUSSION other organs [12, 13]. In these previously mentioned
The present study examined whether the administra- studies, either dexamethasone was administered at sig-
tion of dexamethasone to pregnant rats at different times nificantly higher doses per kilogram body weight or for
during gestation has adverse effects on the kidney. Our more days than that used in the present study and re-
data show that the dosing regimens of dexamethasone sulted in intrauterine growth retardation. While prenatal
used in this study did not produce intrauterine growth dexamethasone can affect intrauterine DNA synthesis
retardation. However, the administration of dexametha- [12, 13], it is clear that the doses and regimen of dexa-
sone at specific times during fetal development produced methasone used in this study did not result in significant
a reduction of nephron number and resulted in hyperten- reductions in renal DNA or protein content compared
sion when the animals were studied as adults. with controls when measured in the first day of life or
Normally, the fetus is protected from maternal gluco- at 60 days of age. It is of interest that the renal DNA
corticoids by placental 11b-hydroxysteroid dehydroge- content at one day of age in the 15 and 16 dexamethasone
group, the group that developed the greatest reductionnase. Pharmacologic inhibition of placental 11b-hydroxy-
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in nephron number was actually greater than that of velopment of hypertension [25, 26, 32]. In the present
study, the rats with the fewest nephrons developed hy-controls. It is clear that gross measurement of DNA,
protein content, and renal weight are not adequate pa- pertension as adults. However, there was no change in
glomerular filtration rate, and it is hard to conceive that arameters to demonstrate important changes that can oc-
cur in nephron number. 30% reduction in nephron number was the sole variable
producing hypertension. There was also a 5% increaseThe administration of dexamethasone to pregnant rats
(0.1 mg/kg/day) throughout gestation resulted in an in- in glomerular surface area in the offspring of rats that
received dexamethasone on days 15 and 16 of gestationcrease in mean blood pressure when the offspring were
studied at 60 days of age [6, 7]. There was over a 50% consistent with compensatory hypertrophy, but this small
increase was not statistically significant. It is possible thatreduction in the number of glomeruli when assessed at
20 days of age, and unlike the present study, there was prenatal glucocorticoids produced other abnormalities
a 30% reduction in glomerular filtration rate when mea- in addition to the reduction in nephron number that
sured at 60 days of age. The one-day-old rats treated predisposes these animals to develop hypertension. It is
with dexamethasone throughout gestation weighed 5.1 6 unclear what this factor may be at present, but prenatal
0.1 g, which was significantly less than the 7.1 6 0.1 g of administration of glucocorticoids may also alter vascular
control rats. These studies show that the administration development resulting in an increased vascular resistance
of dexamethasone throughout gestation produces hyper- when the rats became adults. It is also possible that
tension when the animals are studied as adults. However, prenatal dexamethasone programs the nephrons to de-
daily administration of dexamethasone throughout preg- velop premature glomerulosclerosis. However, we found
nancy produced intrauterine growth retardation, which no evidence for a difference glomerulosclerosis or inter-
itself is a predisposing factor for the development of stitial fibrosis in the histologic evaluation of kidneys from
hypertension [25–28] and renal disease in later life offspring of control rats and offspring of rats that re-
[25, 29]. ceived dexamethasone on days 15 and 16 of gestation.
The present study demonstrates that the administra- In summary, this study examined whether prenatal
tion of two doses of dexamethasone (0.2 mg/kg body wt) dexamethasone programmed rats to develop renal ab-
to pregnant rats does not lead to intrauterine growth normalities and hypertension when they became adults.
retardation. However, prenatal dexamethasone results These data show that there are specific times during
in a paucity of glomeruli and hypertension when the rats development when prenatal dexamethasone resulted in
were studied at 60 to 90 days of age. In addition, there a reduction in nephron number and hypertension when
appears to be a specific time during renal development the rats were studied as adults. The effects of prenatal
when the kidney is susceptible to the adverse effects of dexamethasone were not associated with intrauterine
glucocorticoids. Nephrogenesis commences in the rat at growth retardation. The mechanism whereby prenatal
12 to 13 days of gestation and continues until approxi- dexamethasone produces a reduction in nephron number
mately one week after birth [22, 30, 31]. It is unclear and hypertension is unclear at present but is likely due
why glucocorticoids produced adverse effects only when to an insult at a critical point in renal and/or vascular
administered between 15 and 18 days of gestation. It is development.
possible that there are also critical times during human
renal development when the administration of glucocor- ACKNOWLEDGMENT
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